Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Apr 21, 2008; 14(15): 2388-2393
Published online Apr 21, 2008. doi: 10.3748/wjg.14.2388
Published online Apr 21, 2008. doi: 10.3748/wjg.14.2388
Table 1 Modified Ann-Arbor clinical staging system
| Clinical stage | Number of patients (n) | |
| IE1 | Mucosa + submucosa | 0 |
| IE2 | Muscularis propria + subserosa | 8 |
| IIE1 | Perigastric lymph nodes | 2 |
| IIE2 | Regional lymph nodes | 8 |
| IIIE | Lymph nodes on both sides of the diaphragm | 4 |
| IVE | Visceral metastases or second extranodal site | 12 |
Table 2 Clinical data and response to treatment
| Clinical characteristics | n (%) |
| Dominant site of gastric lesion | |
| Fundus | 10 (29.4) |
| Corpus | 18 (53.0) |
| Antrum | 4 (17.6) |
| Anemia (Hb < 110 g/L) | 21 (61.7) |
| Thrombocytopenia (PLT < 100 × 109/L) | 9 (26.5) |
| Elevated ESR (> 10/1 h) | 16 (47.1) |
| Bone marrow infiltration | 8 (23.5) |
| Constitutional “B” symptoms | 28 (82.4) |
| Answer to therapy | |
| Complete remission | 22 (64.7) |
| Partial remission | 9 (26.5) |
| Stable disease | 1 (2.9) |
| Progressive disease | 2 (5.9) |
- Citation: Todorovic M, Balint B, Jevtic M, Suvajdzic N, Ceric A, Stamatovic D, Markovic O, Perunicic M, Marjanovic S, Krstic M. Primary gastric mucosa associated lymphoid tissue lymphoma: Clinical data predicted treatment outcome. World J Gastroenterol 2008; 14(15): 2388-2393
- URL: https://www.wjgnet.com/1007-9327/full/v14/i15/2388.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.2388